- Pfizer Inc. shares rose 2.15% to $28.57 on Tuesday during a favorable market session.
- The stock outperformed several competitors, such as Johnson & Johnson, Eli Lilly & Co., and Abbott Laboratories.
- Trading volume reached 30.9 M, remaining 13.3 million below its 50-day average volume of 44.2 M.
- Wall Street analysts have updated ratings and price targets for three high-dividend-yielding health care stocks including Perrigo Company PLC, Pfizer Inc, and Bristol-Myers Squibb Co.
- Perrigo reported strong second-quarter financial results, Pfizer advanced its Lyme disease vaccine candidate in Europe, and Bristol-Myers Squibb received FDA accelerated approval for Zenbexus.
- Investors frequently turn to such dividend-yielding stocks during market turbulence as these companies feature high free cash flows and reward shareholders with consistent payouts.
- EP Wealth Advisors LLC purchased 264,001 shares of AT&T Inc. valued at approximately $5,465,000 during the second quarter.
- Several other large institutional investors, including State Street Corp and Bank of America Corp DE, also adjusted their positions in the company.
- AT&T reported a quarterly EPS of $0.65 with revenue of $31.56 billion, alongside announcing a quarterly dividend of $0.2775 per share.